Total Clarity Wealth Management, Inc. Checkpoint Therapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$0.97 - $1.77 $2,910 - $5,310	3,000 New	3,000 $3,000
Q1 2022 Apr 29, 2022	SELL	$1.53 - $3.25 $8,415 - $17,875	-5,500 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$2.68 - $4.46 $8,040 - $13,380	3,000 Added 120.0%	5,500 $17,000
Q3 2021 Oct 21, 2021	BUY	$2.5 - $3.53 $6,250 - $8,825	2,500 New	2,500 $8,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.